,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, myocardial infarction, upper respiratory tract infection, constipation, peripheral neuropathies NEC, embolic and thrombotic events, venous, asthenia, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, insomnia, rash, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, dizziness, hepatic failure, musculoskeletal chest pain, embolic and thrombotic events, venous, rash"
1,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction with fatal outcome, myocardial ischemia, Acute Renal Failure, Tumor Lysis Syndrome, Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, Pulmonary Hypertension, Dyspnea, Hypertension, hypertensive crisis, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, Posterior reversible encephalopathy syndrome, Embryo-fetal Toxicity, congestive heart failure, pulmonary edema, decreased ejection fraction, restrictive cardiomyopathy, cardiac arrest, renal impairment, renal failure, pneumonitis, interstitial lung disease, pulmonary arterial hypertension, deep venous thrombosis, pulmonary embolism, fever, chills, arthralgia, myalgia, facial flushing, facial edema, vomiting, weakness, shortness of breath, hypotension, syncope, chest tightness, angina, increased serum transaminases, seizure, headache, lethargy, confusion, blindness, altered consciousness"
2,MULTAQ,adverse reactions,"New or worsening heart failure, Liver Injury, Pulmonary toxicity, Hypokalemia, Hypomagnesemia, QT prolongation, Diarrhea, Nausea, Abdominal pain, Vomiting, Asthenia, Gastrointestinal disorders, Dyspeptic signs and symptoms, Bradycardia, Rashes (generalized, macular, maculo-papular, erythematous), Pruritus, Eczema, Dermatitis, Dermatitis allergic, Photosensitivity reaction, Dysgeusia, Early increases in creatinine >=10%, QTc prolonged, Atrial flutter with 1:1 atrioventricular conduction, Interstitial lung disease including pneumonitis and pulmonary fibrosis, Anaphylactic reactions including angioedema, Vasculitis, including leukocytoclastic vasculitis"
3,MULTAQ,boxed warnings,"death, stroke, hospitalization for heart failure"
4,MULTAQ,warnings and precautions,"cardiovascular death, heart failure, stroke, new onset heart failure, worsening heart failure, hepatocellular liver injury, acute liver failure requiring transplant, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, hypokalemia, hypomagnesemia, QT interval prolongation, marked increase in serum creatinine, pre-renal azotemia, acute renal failure"
5,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
7,TEFLARO,warnings and precautions,"Serious hypersensitivity (anaphylactic) reactions, Clostridium difficile-associated diarrhea (CDAD), Direct Coombs' test seroconversion, serious skin reactions, mild diarrhea, fatal colitis, increased morbidity and mortality, drug-induced hemolytic anemia, development of drug-resistant bacteria"
8,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, skin erythema, pruritis, thyroid neoplasia"
10,TIVICAY,adverse reactions,"Hypersensitivity reactions, Effects on serum liver biochemistries in patients with hepatitis B or C co-infection, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, Treatment-emergent Adverse Drug Reactions, Abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, Hepatitis, Myositis, Suicidal ideation, attempt, behavior, or completion, Renal impairment, Pruritus, ALT abnormalities, AST abnormalities, Creatine kinase abnormalities, Hyperglycemia, Lipase abnormalities, Total neutrophils abnormalities, Cholesterol increase, HDL cholesterol increase, LDL cholesterol increase, Triglycerides increase, Rash, Depression, Abnormal dreams, Dizziness, Nausea, Diarrhea, Vertigo"
11,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
12,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, cuSCC, cough, constipation, nasopharyngitis, hypophosphatemia, increased alkaline phosphatase, hyponatremia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased ALT, hyperbilirubinemia, increased GGT, hypoalbuminemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QTcF prolongation"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, KRAS mutation-positive pancreatic adenocarcinoma, recurrent NRAS mutation-positive colorectal carcinoma, head and neck carcinoma, glioblastoma, intracranial hemorrhage, gastric hemorrhage, deep venous thrombosis, pulmonary embolism, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, hypotension, rigors or chills, dehydration, renal failure, secondary infections of the skin, hemolytic anemia"
14,HORIZANT,adverse reactions,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, confusional state, breast enlargement, gynecomastia, elevated creatine kinase"
15,HORIZANT,warnings and precautions,"driving impairment, somnolence/sedation, dizziness, suicidal thoughts or behaviors, somnolence, fatigue/asthenia, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, withdrawal seizure, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, tumors, breast cancer, brain tumors, lung cancer, adrenal tumor, non-Hodgkin's lymphoma, endometrial carcinoma in situ, tumor worsening"
16,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, renal failure, stomatitis, dyspepsia, urinary tract infection, skin infections, sinusitis, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, oropharyngeal pain, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, gastroesophageal reflux disease, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock (fatal), urticaria, angioedema"
17,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, fatal bleeding events, infections, non-fatal infections, Grade 3 or greater infections, progressive multifocal leukoencephalopathy (PML), neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, other malignancies, skin cancers, other carcinomas, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, malformations, reduced fetal weights"
18,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions"
19,ULORIC,warnings and precautions,"gout flares, cardiovascular thromboembolic events, hepatic failure, fatal hepatic failure, non-fatal hepatic failure, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes, transaminase elevations, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, severe drug-induced liver injury"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, Serious Infections, Malignancies, Heart Failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, Anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, Angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, Optic neuritis, retinal hemorrhage, uveitis, Bleeding, injection site reactions, Elevated liver enzymes, hepatitis, Alopecia totalis, Anxiety, bipolar disorder, suicide attempt, Nephrotic syndrome, renal failure, Menstrual disorder, Dermatitis, erythema nodosum, Thrombophlebitis, vasculitis, Headache, Hypertension, Back pain, Pharyngitis, Acute bronchitis, Fatigue, herpes infections, lower respiratory tract infections, cellulitis, pyelonephritis, lupus-like syndrome, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis"
21,CIMZIA,boxed warnings,"Active tuberculosis, reactivation of latent tuberculosis, invasive fungal infections (including histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis), bacterial infections, viral infections, infections due to opportunistic pathogens (including Legionella and Listeria), serious infections leading to hospitalization or death, bacterial sepsis, lymphoma, other malignancies"
22,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, other malignancies, heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, tuberculosis, opportunistic infections, worsening congestive heart failure, new onset CHF, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, hepatosplenic T-cell lymphoma, acute and chronic leukemia, new onset or exacerbation of central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, optic neuritis, peripheral neuropathy, aplastic anemia, leukopenia, thrombocytopenia"
23,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
24,KALYDECO,warnings and precautions,"Elevated transaminases, increased transaminase levels, non-congenital lens opacities/cataracts"
25,FULYZAQ,adverse reactions,"Upper respiratory tract infection, Bronchitis, Cough, Flatulence, Increased bilirubin, Nausea, Back pain, Arthralgia, Urinary tract infection, Nasopharyngitis, Musculoskeletal pain, Hemorrhoids, Giardiasis, Anxiety, Increased alanine aminotransferase, Abdominal distension, Abdominal pain, Acne, Increased aspartate aminotransferase, Increased conjugated bilirubin, Increased unconjugated blood bilirubin, Constipation, Depression, Dermatitis, Dizziness, Dry mouth, Dyspepsia, Gastroenteritis, Herpes zoster, Nephrolithiasis, Pain in extremity, Pollakiuria, Procedural pain, Seasonal allergy, Sinusitis, Decreased white blood cell count"
26,FULYZAQ,warnings and precautions,disease may worsen
27,QUTENZA,adverse reactions,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
28,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, irritation of airway, transient increases in blood pressure, procedural pain, increases in blood pressure"
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome (acute febrile neutrophilic dermatosis), cutaneous vasculitis, thrombocytopenia"
30,GRANIX,warnings and precautions,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, Capillary Leak Syndrome, anaphylaxis, fever, lung infiltrates, respiratory distress, hypotension, hypoalbuminemia, edema, hemoconcentration, Tumor Growth Stimulatory Effects on Malignant Cells"
31,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, anaphylaxis, angioedema, serious skin reactions (bullous eruption)"
32,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, decreased exposure to lumefantrine, decreased efficacy, increased concentrations of artemether and/or lumefantrine, potentiate QT prolongation, loss of antimalarial efficacy, reduced effectiveness of hormonal contraceptives, increased risk of adverse effects, recrudescence"
33,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions and Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, Ear and labyrinth disorders, Eye disorders, Visual impairment, Gastrointestinal disorders, Diarrhea, Constipation, Abdominal pain, Gastritis, General disorders and administration site conditions, Asthenia, Gait disturbance, Peripheral edema, Infections and Infestations, Urinary tract infections, Injury, poisoning and procedural complications, Fall, Metabolism and nutrition disorders, Nervous system disorders, Balance disorder, Dysarthria, Memory impairment, Nystagmus, Psychiatric disorders, Depression, Insomnia, Respiratory, thoracic and mediastinal disorders, Cough, Skin and subcutaneous tissue disorders, Rash, Vascular disorders, Hypertension, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase"
34,APTIOM,warnings and precautions,"Suicidal thoughts or behavior, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Anaphylactic Reactions, Angioedema, Hyponatremia, Dizziness, Disturbance in gait and coordination, Somnolence, Fatigue, Cognitive dysfunction, Visual changes, Increased seizure frequency, Status epilepticus, Drug Induced Liver Injury, Abnormal thyroid function tests, Stevens-Johnson Syndrome (SJS), Toxic epidermal necrolysis (TEN), Hepatitis, Nephritis, Hematological abnormalities, Myocarditis, Myositis, Fever, Rash, Lymphadenopathy, Seizures, Severe nausea/vomiting, Dehydration, Severe gait instability, Injury, Hypochloremia, Ataxia, Vertigo, Balance disorder, Gait disturbance, Nystagmus, Abnormal coordination, Asthenia, Malaise, Hypersomnia, Sedation, Lethargy, Memory impairment, Disturbance in attention, Amnesia, Confusional state, Aphasia, Speech disorder, Slowness of thought, Disorientation, Psychomotor retardation, Diplopia, Blurred vision, Impaired vision, Mild to moderate elevations in transaminases, Rare cases with concomitant elevations of total bilirubin, Decreases in serum T3 and T4"
35,PROLIA,adverse reactions,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, pancreatitis, Anemia, Angina pectoris, Atrial fibrillation, Vertigo, Abdominal pain upper, Flatulence, Gastroesophageal reflux disease, Edema peripheral, Asthenia, Upper respiratory tract infection, Pneumonia, Pharyngitis, Herpes zoster, Bone pain, Myalgia, Spinal osteoarthritis, Sciatica, Insomnia, Rash, Pruritus, New Malignancies, cataracts, Drug-related hypersensitivity reactions: anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe cases of musculoskeletal pain, Marked elevation in serum PTH"
36,PROLIA,warnings and precautions,"hypersensitivity including anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections including skin infections, dermatitis, rashes, eczema, severe bone, joint, muscle pain, suppression of bone turnover, hypotension, dyspnea, throat tightness, facial and upper airway edema, pruritus, urticaria, marked elevations of serum parathyroid hormone (PTH), serious skin infections, infections of the abdomen, urinary tract, ear infections, endocarditis, opportunistic infections"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal pain, Vomiting, Fatigue, Chills, Chest pain, Cytokine release syndrome, Other pathogen infections, Bacterial infections, Fungal infections, Viral infections, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased weight, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Hypotension, Hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm"
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome (CRS), life-threatening, fatal, Neurological toxicities, severe, life-threatening, fatal"
39,BLINCYTO,warnings and precautions,"Cytokine Release Syndrome (CRS), life-threatening or fatal CRS, infusion reactions, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), neurological toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, serious infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, Tumor Lysis Syndrome (TLS), Neutropenia, febrile neutropenia, loss of consciousness, transient elevations in liver enzymes, Grade 3 or greater elevations in liver enzymes, leukoencephalopathy, preparation and administration errors"
40,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, upper respiratory infection, electrocardiogram abnormal, dizziness, gastroenteritis viral, Non-arteritic anterior ischemic optic neuropathy (NAION)"
41,STENDRA,warnings and precautions,"hypotension, erection lasts greater than 4 hours, sudden loss of vision, sudden decrease or loss of hearing, transient decreases in sitting blood pressure, symptomatic hypotension (e.g., dizziness, lightheadedness, fainting), increase in heart rate, decrease in standing blood pressure, dizziness, headache"
42,XIAFLEX,adverse reactions,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, flexor tendon rupture, pruritus, tenderness, injection site swelling, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, ecchymosis, penile ecchymoses, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain"
43,XIAFLEX,boxed warnings,"corporal rupture (penile fracture), penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma"
44,XIAFLEX,warnings and precautions,"tendon rupture, serious injury to the injected finger/hand, possible permanent injury, tendon rupture, ligament damage, skin laceration, corporal rupture (penile fracture), serious injury to the penis, possible permanent injury, hypersensitivity reactions, anaphylaxis, abnormal coagulation, flexor tendon ruptures, damage to collagen-containing structures, permanent injury, tendon rupture, ligament damage, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), skin laceration requiring skin graft, corporal rupture, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, surgical intervention, damage to collagen-containing structures, injury, corporal rupture (penile fracture), mild allergic reactions (pruritus), severe allergic reactions, anaphylaxis, IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage, penile hematoma, penile ecchymosis"
45,XEOMIN,adverse reactions,"Hypersensitivity, Dysphagia, Breathing Difficulties, Spread of Effects from Toxin, Neck pain, Muscle weakness, Injection site pain, Musculoskeletal pain, Eyelid ptosis, Dry eye, Dry mouth, Diarrhea, Headache, Visual impairment, Dyspnea, Nasopharyngitis, Respiratory tract infection, Facial paresis, Injection site hematoma, Eyelid edema, Eye swelling, Nausea, Flu-like symptoms, Injection site reaction, Allergic dermatitis, Localized allergic reactions like swelling, Edema, Erythema, Pruritus, Rash, Herpes zoster, Muscle spasm, Dysarthria, Myalgia"
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, exacerbated clinical effects, corneal exposure, corneal ulceration, reduced blinking, corneal exposure with possible ulceration or perforation, diplopia, ptosis, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, swallowing difficulties, breathing difficulties, severe dysphagia, aspiration, critical loss of breathing capacity, respiratory failure, severe dysphagia, respiratory compromise, persistent epithelial defect, ectropion, narrow angle glaucoma, ecchymosis"
48,GILOTRIF,adverse reactions,"diarrhea, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, serious adverse reactions, diarrhea, vomiting, dyspnea, fatigue, hypokalemia, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, dose reductions, diarrhea, rash/acne, paronychia, stomatitis, discontinuation of therapy, diarrhea, ILD, paronychia, ventricular dysfunction, gastrointestinal disorders, stomatitis, nausea, vomiting, cheilitis, skin and subcutaneous tissue disorders, rash/dermatitis acneiform, pruritus, dry skin, infections and infestations, paronychia, cystitis, metabolism and nutrition disorders, decreased appetite, respiratory, thoracic and mediastinal disorders, epistaxis, rhinorrhea, investigations, weight decreased, general disorders and administration site conditions, pyrexia, eye disorders, conjunctivitis, laboratory abnormalities, alanine aminotransferase increased, hypokalemia, aspartate aminotransferase increased, pancreatitis"
49,GILOTRIF,warnings and precautions,"Diarrhea, dehydration, renal failure, Bullous disorders, Exfoliative Skin Disorders, blistering lesions, exfoliating lesions, Interstitial lung disease (ILD), pulmonary symptoms, Hepatic toxicity, Fatal hepatic impairment, liver test abnormalities, Keratitis, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, Embryofetal toxicity, fetal harm, abortions"
50,TREANDA,adverse reactions,"Myelosuppression, Infections, Anaphylaxis, Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, Pyrexia, Nausea, Vomiting, Fatigue, Diarrhea, Constipation, Anorexia, Cough, Headache, Weight decreased, Dyspnea, Rash, Stomatitis, Lymphopenia, Anemia, Leukopenia, Thrombocytopenia, Neutropenia, Asthenia, Malaise, Weakness, Dry mouth, Somnolence, Mucosal inflammation, Worsening hypertension, Hypertensive crisis, Hypersensitivity, Nasopharyngitis, Infection, Herpes simplex, Hyperuricemia, Pruritus, Hemoglobin Decreased, Platelets Decreased, Leukocytes Decreased, Lymphocytes Decreased, Neutrophils Decreased, Bilirubin elevations, Increased bilirubin, Increases in AST, Increases in ALT, Creatinine levels changes, Tachycardia, Constipation, Stomatitis, Abdominal pain, Dyspepsia, Gastroesophageal reflux disease, Abdominal pain upper, Abdominal distension, Chills, Edema peripheral, Chest pain, Infusion site pain, Pain, Catheter site pain, Herpes zoster, Upper respiratory tract infection, Urinary tract infection, Sinusitis, Pneumonia, Febrile neutropenia, Oral candidiasis, Weight decreased, Anorexia, Dehydration, Decreased appetite, Hypokalemia, Back pain, Arthralgia, Pain in extremity, Bone pain, Headache, Dizziness, Dysgeusia, Insomnia, Anxiety, Depression, Cough, Dyspnea, Pharyngolaryngeal pain, Wheezing, Nasal congestion, Dry skin, Night sweats, Hyperhidrosis, Hypotension, Hemolysis, Dysgeusia/taste disorder, Atypical pneumonia, Sepsis, Herpes zoster, Erythema, Dermatitis, Skin necrosis, Anaphylaxis, Injection or infusion site reactions, Phlebitis, Irritation, Pain, Swelling, Pneumocystis jiroveci pneumonia, Pneumonitis, SJS, TEN"
51,TREANDA,warnings and precautions,"myelosuppression, death from myelosuppression, infections, fever, signs of infection, Anaphylaxis, Infusion Reactions, severe anaphylactic reactions, Tumor Lysis Syndrome, Acute renal failure, death from Tumor Lysis Syndrome, Skin Reactions, SJS, TEN, fatal skin reactions, Other Malignancies, pre-malignant diseases, malignant diseases, Extravasation, Embryo-fetal toxicity, fetal harm, neutropenic sepsis, diffuse alveolar hemorrhage, Grade 3 thrombocytopenia, pneumonia from opportunistic infection (CMV), pneumonia, sepsis, septic shock, fever from infusion reactions, chills, pruritus, rash from infusion reactions, severe anaphylactic and anaphylactoid reactions, allergic-type reactions, rash from skin reactions, toxic skin reactions, bullous exanthema, toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS), myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, erythema from extravasation, marked swelling from extravasation, pain from extravasation, redness from infusion site, swelling from infusion site, infection from infusion site, necrosis from infusion site, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights"
52,CHOLINE,adverse reactions,mild injection site reaction
53,CHOLINE,warnings and precautions,"Imaging errors, blood PSA levels < 2 ng/mL associated with poor imaging performance, allergic reactions, anaphylaxis, radiation risk, increased risk for cancer, false positive 11 C-choline PET images, false negative results, tissue inflammation associated with false positive 11 C-choline PET images, prostatic hyperplasia associated with false positive 11 C-choline PET images"
54,ERWINAZE,adverse reactions,"Hypersensitivity reactions, Pancreatitis, Glucose intolerance, Thrombosis and hemorrhage, Systemic hypersensitivity, Hyperglycemia, Transaminases abnormal, Fever, Local reactions, Vomiting, Nausea, Hyperbilirubinemia, Abdominal pain/discomfort, Diarrhea, Allergy, Coagulopathy (hemorrhage, thrombosis or infarct), Hyperlipidemia, Ketoacidosis, CNS events (hemorrhage, thrombosis or infarction, and cerebral venous thrombosis), Hepatobiliary disorders"
55,ERWINAZE,warnings and precautions,"Serious hypersensitivity reactions, anaphylaxis, Severe or hemorrhagic pancreatitis, Glucose intolerance, hyperglycemia, Thrombosis, hemorrhage, Grade 3 and 4 hypersensitivity reactions, abdominal pain > 72 hours, amylase elevation >= 2.0 x ULN, Serious thrombotic events, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
56,TRULICITY,adverse reactions,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, fatigue, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, systemic hypersensitivity reactions (e.g., severe urticaria, systemic rash, facial edema, lip swelling), injection-site reactions (e.g., injection-site rash, erythema), PR Interval Prolongation, first degree Atrioventricular (AV) Block, amylase and lipase increase"
57,TRULICITY,boxed warnings,"thyroid C-cell tumors (adenomas and carcinomas), medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
58,TRULICITY,warnings and precautions,"pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, severe gastrointestinal reactions, thyroid C-cell tumors, medullary thyroid carcinoma (MTC), acute renal failure, worsening of chronic renal failure, nausea, vomiting, diarrhea, dehydration"
59,ADREVIEW,adverse reactions,"Serious hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
60,ADREVIEW,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, serious reactions in premature or low birth-weight infants, increased radiation exposure, decreased quality of AdreView images, iodine 123 accumulation in the thyroid, false negative imaging results, clinically significant withdrawal symptoms, toxicity (hypotension, metabolic acidosis), increased incidence of kernicterus, deaths in preterm infants, decreased cardiac uptake of AdreView, increased long term risk for thyroid neoplasia, transient episode of hypertension"
61,DOTAREM,adverse reactions,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
62,DOTAREM,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal or debilitating fibrosis affecting the skin, muscle and internal organs"
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactoid/anaphylactic reactions with cardiovascular manifestations, Anaphylactoid/anaphylactic reactions with respiratory manifestations, Anaphylactoid/anaphylactic reactions with cutaneous manifestations, death from hypersensitivity reactions, fatal or debilitating fibrosis affecting the skin, fatal or debilitating fibrosis affecting the muscle, fatal or debilitating fibrosis affecting internal organs, acute kidney injury requiring dialysis, tissue irritation"
64,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, intracranial hemorrhage, hemorrhagic stroke, subarachnoid bleeds, subdural bleeds, gastrointestinal bleeds, hypersensitivity, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding in a critical area or organ, intraocular bleeding, intraspinal bleeding, intramuscular bleeding with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, clinical myocardial infarction, abdominal pain upper, abdominal pain, abdominal discomfort, epigastric discomfort, gastritis, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, angioedema, thrombocytopenia, esophageal ulcer"
65,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term or permanent paralysis, neurological impairment"
66,PRADAXA,warnings and precautions,"serious and fatal bleeding, thrombotic events, significant bleeding, fatal bleeding, blood loss, active pathological bleeding, bleeding, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions, spinal hematoma, paralysis, neurological impairment, midline back pain, sensory and motor deficits, numbness, tingling, weakness in lower limbs, bowel and/or bladder dysfunction"
67,ELIQUIS,adverse reactions,"Increased risk of thrombotic events after premature discontinuation, Bleeding, Spinal/epidural anesthesia or puncture, Intracranial bleed, Hemorrhagic stroke, Gastrointestinal (GI) bleed, Fatal bleeding, Intracranial, Non-intracranial, Hypersensitivity reactions, Syncope, Nausea, Anemia, Contusion, Hemorrhage, Postprocedural hemorrhage, Transaminases increased, Aspartate aminotransferase increased, Gamma-glutamyltransferase increased, Thrombocytopenia, Hypotension, Epistaxis, Gastrointestinal hemorrhage, Hematochezia, Liver function test abnormal, Blood alkaline phosphatase increased, Blood bilirubin increased, Hematuria, Wound secretion, Incision-site hemorrhage, Operative hemorrhage, Gingival bleeding, Hemoptysis, Muscle hemorrhage, Ocular hemorrhage, Rectal hemorrhage, Hemorrhagic anemia, Hemorrhoidal hemorrhage, Traumatic hematoma, Periorbital hematoma, Vaginal hemorrhage, Metrorrhagia, Menometrorrhagia, Genital hemorrhage, Ecchymosis, Skin hemorrhage, Petechiae, Conjunctival hemorrhage, Retinal hemorrhage, Eye hemorrhage, Blood urine present, Occult blood positive, Red blood cells urine positive, Injection-site hematoma, Vessel puncture-site hematoma"
68,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term or permanent paralysis"
69,ELIQUIS,warnings and precautions,"serious, potentially fatal bleeding, increased risk of thrombotic events, stroke, bleeding, pathological hemorrhage, epidural or spinal hematoma, long-term or permanent paralysis, neurological impairment"
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, dyspnea, urticaria, venous thrombosis"
71,ZERBAXA,warnings and precautions,"Decreased efficacy in patients with baseline CrCl of 30 to <=50 mL/min, Serious hypersensitivity (anaphylactic) reactions, Clostridium difficile-associated diarrhea (CDAD), fatal colitis, Development of Drug-Resistant Bacteria"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
73,FERRIPROX,boxed warnings,"agranulocytosis, serious infections, death, neutropenia, infection"
74,FERRIPROX,warnings and precautions,"infection, fetal harm, agranulocytosis, neutropenia, death, embryofetal death, malformations, increased ALT values, increased serum ALT levels, increase in both ALT and AST, decreased plasma zinc concentrations"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma"
76,DALVANCE,warnings and precautions,"Serious hypersensitivity (anaphylactic) and skin reactions, Rapid intravenous infusion reactions, ALT elevations, Clostridium difficile-associated diarrhea (CDAD), flushing of the upper body, urticaria, pruritus, rash, abnormalities in liver tests (ALT, AST, bilirubin), mild diarrhea to fatal colitis"
77,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, cough post-inhalation, respiratory-related deaths, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness"
78,ARCAPTA,boxed warnings,asthma-related death
79,ARCAPTA,warnings and precautions,"clinically significant cardiovascular effects, fatal, Immediate hypersensitivity reactions, Life-threatening paradoxical bronchospasm, asthma-related death, Serious asthma-related events, death, deterioration of disease, acute episodes of bronchospasm, overdose, fatalities, difficulties in breathing, swallowing, swelling of tongue, lips and face, urticaria, skin rash, paradoxical bronchospasm, increases in pulse rate, systolic or diastolic blood pressure, symptoms, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, significant hypokalemia, increases in plasma glucose"
80,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
81,CERDELGA,warnings and precautions,"prolongation of the PR, QTc, and/or QRS cardiac intervals, cardiac arrhythmias"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash (includes generalized, macular, papular, pruritic), Pruritus (includes generalized), Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor"
83,GADAVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal or debilitating fibrosis affecting the skin, muscle and internal organs"
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactic reactions, hypersensitivity reactions with cardiovascular manifestations, hypersensitivity reactions with respiratory manifestations, hypersensitivity reactions with cutaneous manifestations, death from hypersensitivity reactions, acute kidney injury, moderate irritation from extravasation, overestimation of extent of malignant disease in MRI of the breast"
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, increased ALT, increased AST, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, abdominal pain (abdominal pain, upper abdominal pain, abdominal discomfort, epigastric discomfort), Esophageal disorder (dyspepsia, gastroesophageal reflux disease, dysphagia), Fatigue (fatigue, asthenia), Rash (rash, maculopapular rash, acneiform dermatitis), neuropathy (paresthesia, muscular weakness, gait disturbance, peripheral neuropathy, hypoesthesia, peripheral sensory neuropathy, dysesthesia, neuralgia, peripheral motor neuropathy, hypotonia, polyneuropathy), vision disorder (vision impairment, blurred vision, photopsia, accommodation disorder, presbyopia, reduced visual acuity), prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased"
86,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, Interstitial Lung Disease (ILD)/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity, elevations in alanine aminotransferase (ALT), jaundice, elevations in aspartate aminotransferase (AST), total bilirubin, ventricular tachyarrhythmias, Torsade de pointes, sudden death, sinus bradycardia, skeletal anomalies"
87,XALKORI,adverse reactions,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, Electrocardiogram QT prolonged, Vision disorder, Vomiting, Diarrhea, Constipation, Dyspepsia, Dysphagia, Abdominal pain, Pyrexia, Weight increased, Pain in extremity, Muscle spasm, Dizziness, Headache, fatigue, neuropathy, rash, renal cyst, ILD, syncope, Neutropenia, Lymphopenia, ALT elevation, AST elevation, Hypophosphatemia, pneumonia, acute respiratory distress syndrome, arrhythmia, respiratory failure, sepsis, Hypokalemia, hepatic failure"
88,XALKORI,warnings and precautions,"Fatal hepatotoxicity, Interstitial Lung Disease (ILD)/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, Concurrent elevations in alanine aminotransferase (ALT) or aspartate aminotransferase (AST) greater than or equal to three times the upper limit of normal (ULN) and total bilirubin greater than or equal to two times the ULN, Elevations in ALT or AST greater than five times the ULN, Severe, life-threatening, or fatal interstitial lung disease (ILD)/pneumonitis, QTcF (corrected QT by the Fridericia method) greater than or equal to 500 ms, Increase from baseline QTcF greater than or equal to 60 ms, Torsade de pointes, Polymorphic ventricular tachycardia, Signs/symptoms of serious arrhythmia, Symptomatic bradycardia, Heart rate less than 50 beats per minute, Grade 3 syncope, Grade 4 visual field defect with vision loss, Optic atrophy, Optic nerve disorder, Embryotoxicity, Fetotoxicity"
89,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, swelling of tongue, swelling of throat"
90,BEPREVE,warnings and precautions,"Based on the provided structured product label excerpt, there are no explicit mentions of adverse drug reactions in the text. The excerpt focuses on warnings, precautions, and instructions for use rather than detailing specific adverse reactions. Therefore, no adverse drug reactions can be extracted from this text."
91,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, increases in serum creatinine, low hemoglobin, low hematocrit, low RBC counts, high and low markedly abnormal platelet counts, high and low markedly abnormal WBC counts, rash, pruritus, angioedema"
92,EDARBI,boxed warnings,"fetal toxicity, injury to the developing fetus, death to the developing fetus"
93,EDARBI,warnings and precautions,"fetal renal function reduction, fetal and neonatal morbidity increase, fetal and neonatal death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure, death, increases in serum creatinine, increases in blood urea nitrogen"
94,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, Urinary retention, Skin discoloration, Neuropsychiatric symptoms, Dizziness, Somnolence, QT interval effect, Suicidal behavior and ideation, Withdrawal seizures, Fatigue, Confusional state, Vertigo, Tremor, Abnormal coordination, Diplopia, Disturbance in attention, Memory impairment, Asthenia, Blurred vision, Gait disturbance, Aphasia, Dysarthria, Balance disorder, Nausea, Constipation, Dyspepsia, Influenza, Weight increased, Paresthesia, Amnesia, Dysphasia, Anxiety, Disorientation, Psychotic disorder, Dysuria, Urinary hesitation, Hematuria, Chromaturia, Increased appetite, Hallucinations, Myoclonus, Peripheral edema, Hypokinesia, Dry mouth, Dysphagia, Hyperhydrosis, Malaise, Increased liver enzymes, Rash, Nystagmus, Dyspnea, Leukopenia, Muscle spasms, Alopecia, Nephrolithiasis, Syncope, Neutropenia, Thrombocytopenia, Euphoric mood, Renal colic, Coma, Encephalopathy"
95,POTIGA,boxed warnings,"retinal abnormalities, vision loss, damage to the photoreceptors, abnormal visual acuity, decreased visual acuity, retinal pigmentary abnormalities, vision changes"
96,POTIGA,warnings and precautions,"urinary retention, skin discoloration, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts or behaviors, retinal abnormalities, vision loss, funduscopic abnormalities, perivascular pigmentation, retinal pigment epithelium clumping, abnormal visual acuity, retinal dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, abnormal fluorescein angiography, diminished sensitivity on visual field testing, urinary hesitation, dysuria, hydronephrosis, renal function impairment, blue skin discoloration, grey-blue skin discoloration, brown skin discoloration, skin, scleral, nail, mucous membrane discoloration, withdrawal seizures"
97,TUDORZA,adverse reactions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
98,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, bronchospasm, anaphylaxis, eye pain or discomfort, blurred vision, visual halos, colored images, red eyes from conjunctival congestion, corneal edema, difficulty passing urine, painful urination, urticaria, rash, itching"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, portal vein thromboses, abdominal pain, toothache, vitamin D deficiency, pain in extremity, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, Thrombotic microangiopathy with acute renal failure"
100,PROMACTA,boxed warnings,hepatic decompensation
101,PROMACTA,warnings and precautions,"Hepatotoxicity, Portal vein thrombosis, Hepatic decompensation, Ascites, Encephalopathy, Liver enzyme elevations, Indirect hyperbilirubinemia, Increased direct bilirubin, Clinical symptoms of liver injury, Evidence for hepatic decompensation, Thrombotic event, Venous and arterial events, Thrombotic complications, Cataracts"
102,INLYTA,adverse reactions,"diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia (hand-foot) syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes (absolute) decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, lipase increased, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
103,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, reversible posterior leukoencephalopathy syndrome (RPLS), proteinuria, liver enzyme elevation, fetal harm"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, exacerbation of existing ischemic heart disease, arrhythmias, congestive heart failure, Headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope"
105,NORTHERA,boxed warnings,supine hypertension
106,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular risk, Hyperpyrexia, confusion, exacerbate symptoms in ischemic heart disease, exacerbate symptoms in arrhythmias, exacerbate symptoms in congestive heart failure, Allergic reactions, neuroleptic malignant syndrome (NMS), fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, allergic-type reactions, bronchial asthma"
107,JARDIANCE,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), urinary tract infections, female genital mycotic infections, upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, nausea, thirst (including polydipsia), volume depletion (e.g., blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypotension, hypovolemia, orthostatic hypotension, syncope), increased urination (e.g., polyuria, pollakiuria, nocturia), increases in serum creatinine, decreases in eGFR, hypoglycemia, genital mycotic infections (e.g., vaginal mycotic infection, vaginal infection, genital infection fungal, vulvovaginal candidiasis, vulvitis), phimosis, urinary tract infections (e.g., urinary tract infection, asymptomatic bacteriuria, cystitis), increase in Low-Density Lipoprotein Cholesterol (LDL-C), increase in Hematocrit"
108,JARDIANCE,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation"
110,FANAPT,boxed warnings,"increased mortality, death, cardiovascular (e.g., heart failure, sudden death), infectious (e.g., pneumonia)"
111,FANAPT,warnings and precautions,"increased risk of death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, Dyslipidemia, Weight Gain, metabolic changes, cardiovascular/cerebrovascular risk, Seizures, Orthostatic hypotension, dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive and motor impairment, hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, body temperature regulation, Dysphagia, aspiration pneumonia, somnolence, sedation"
112,TANZEUM,adverse reactions,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, increased gamma glutamyltransferase (GGT), heart rate increase"
113,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, acute pancreatitis, persistent severe abdominal pain, vomiting, pruritus, rash, dyspnea, acute renal failure, worsening of chronic renal failure, nausea, vomiting, diarrhea, dehydration"
115,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear, endophthalmitis"
116,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, deaths of unknown cause"
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, arrhythmia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, muscle spasms, dizziness, headache, dysuria, hypotension, gastritis, intestinal obstruction"
118,JEVTANA,boxed warnings,"neutropenic deaths, neutropenia, generalized rash/erythema, hypotension, bronchospasm"
119,JEVTANA,warnings and precautions,"Bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, hypersensitivity reactions, nausea, vomiting, diarrhea, mortality related to diarrhea, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, renal failure, anemia, thrombocytopenia, pancytopenia, neutropenic deaths, sepsis, septic shock, generalized rash/erythema, hypotension, bronchospasm, electrolyte imbalance, ileus, enterocolitis, abdominal pain, tenderness, fever, persistent constipation, obstructive uropathy, embryotoxic, fetotoxic, abortifacient"
120,YERVOY,adverse reactions,"Immune-mediated enterocolitis, Immune-mediated hepatitis, Immune-mediated dermatitis, Immune-mediated neuropathies, Immune-mediated endocrinopathies, Other immune-mediated adverse reactions including ocular manifestations, Fatigue, Diarrhea, Pruritus, Rash, Colitis, Diarrhea (32%, 5% Grade 3-5), Colitis (8%, 5% Grade 3-5), Pruritus (31%, 0% Grade 3-5), Rash (29%, 2% Grade 3-5), Fatigue (41%, 7% Grade 3-5), Any Immune-mediated Adverse Reaction (15%, 12%), Enterocolitis (7%, 7%), Hepatotoxicity (1%, 2%), Dermatitis (2%, 3%), Neuropathy (1%, <1%), Endocrinopathy (4%, 1%), Hypopituitarism (4%, 1%), Adrenal insufficiency (0%, 1%), Pneumonitis (0%, <1%), Meningitis (0%, <1%), Nephritis (1%, 0%), Eosinophilia (1%, 0%), Pericarditis (0%, <1%), Urticaria (2%), Large intestinal ulcer, Esophagitis, Acute respiratory distress syndrome, Renal failure, Infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)"
121,YERVOY,boxed warnings,"enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy"
122,YERVOY,warnings and precautions,"severe and fatal immune-mediated reactions, severe reactions, moderate immune-mediated adverse reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, severe, life-threatening, or fatal immune-mediated enterocolitis, moderate enterocolitis, intestinal perforation, complications, hospitalized for severe enterocolitis, severe, life-threatening, or fatal hepatotoxicity, fatal hepatic failure, moderate hepatotoxicity, liver function test abnormalities, immune-mediated hepatitis, severe, life-threatening, or fatal immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic, bullous, or hemorrhagic manifestations, severe dermatitis, moderate dermatitis, fatal Guillain-Barre syndrome, severe peripheral motor neuropathy, myasthenia gravis, Guillain-Barre syndrome, severe to life-threatening immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, moderate endocrinopathy, hypothyroidism, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis"
123,FARXIGA,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, female genital mycotic infections, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus"
124,FARXIGA,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer"
125,PICATO,adverse reactions,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
126,PICATO,warnings and precautions,"severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, vesiculation/pustulation, erosion/ulceration, erythema, crusting, swelling, anaphylaxis, allergic contact dermatitis"
127,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease and Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, Blood pressure increased, Dry mouth, Vomiting, Fatigue, Chills, Feeling jittery, Tremor, Disturbance in attention, Insomnia, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, Proteinuria, Stevens-Johnson syndrome"
128,PRISTIQ,boxed warnings,suicidal thoughts and behaviors
129,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, activation of mania/hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, worsening of depression, emergence of suicidality, unusual changes in behavior, suicidal thinking, suicidal behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea), increases in blood pressure, gastrointestinal bleeding, ecchymosis, hematoma, epistaxis, petechiae, life-threatening hemorrhages, pupillary dilation, dizziness, nausea, headache, irritability, insomnia, diarrhea, anxiety, fatigue, abnormal dreams, hyperhidrosis, dysphoric mood, sensory disturbances (e.g., paresthesia, such as electric shock sensations), confusion, lethargy, emotional lability, tinnitus, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death, progressive dyspnea, cough, chest discomfort"
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, skin discoloration, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Urine RBC (Hematuria), Proteinuria, serum creatinine increase, decreased estimated creatinine clearance, alkaline phosphatase elevation, bilirubin elevation, serum glucose abnormalities, glycosuria, neutrophils decrease, fasting cholesterol increase, fasting triglycerides increase, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia"
131,STRIBILD,boxed warnings,"Lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B"
132,STRIBILD,warnings and precautions,"acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, renal impairment, proximal renal tubulopathy, acute renal failure, bone pain, pain in extremities, fractures, muscular pain, weakness, decreases in bone mineral density, osteomalacia, arthralgias, muscle pain, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
133,NULOJIX,adverse reactions,"PTLD, CNS PTLD, other malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, fungal infections, tuberculosis, herpes infections, BK virus-associated nephropathy, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, hypotension, proteinuria, new-onset diabetes after transplantation (NODAT), dyslipidemia, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, abdominal pain upper, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, hypotension, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, including aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, including acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
134,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder (PTLD), malignancies, serious infections, increased susceptibility to infection, possible development of malignancies, graft loss, death"
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), increased risk of other malignancies, Progressive Multifocal Leukoencephalopathy (PML), increased risk of bacterial infections, increased risk of viral infections, increased risk of fungal infections, increased risk of protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy leading to kidney graft loss, cytomegalovirus, pneumocystis, liver transplant not recommended, acute rejection, graft loss with corticosteroid minimization, avoid use of live vaccines"
136,LUMIZYME,adverse reactions,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, paresthesia, local swelling, diarrhea, pruritus, throat tightness, edema peripheral, rash papular, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions"
137,LUMIZYME,boxed warnings,"anaphylactic reactions, hypersensitivity reactions, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload"
138,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, chest discomfort, chest pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension, increased blood pressure, flushing, feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, immune-mediated cutaneous reactions, necrotizing skin lesions, systemic immune-mediated reactions, type III immune-mediated reactions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, acute cardiorespiratory failure, cardiac hypertrophy, fluid overload, ventricular arrhythmias, bradycardia, cardiac arrest, death, cardiac resuscitation, defibrillation, loss of motor function, ventilator dependence"
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin laboratory values, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
140,EOVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal or debilitating fibrosis affecting the skin, muscle, and internal organs"
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, anaphylactoid/hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, shock, fatal or debilitating fibrosis affecting the skin, muscle and internal organs, acute kidney injury, drug-induced kidney toxicity, hypersensitivity reactions, anaphylactic reactions, acute kidney injury requiring dialysis, local tissue reactions, myocyte necrosis, inflammation, falsely high or low serum iron values"
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation"
143,BELEODAQ,warnings and precautions,"Thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, serious infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, nausea, vomiting, diarrhea, fetal harm, teratogenicity, embryo-fetal lethality"
144,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, diarrhea, vomiting, dry mouth, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
145,VICTRELIS,warnings and precautions,"birth defects, fetal death, anemia, decrease in hemoglobin concentrations, worsening of neutropenia, serious acute hypersensitivity reactions, urticaria, angioedema, dyspnea, exertional dyspnea, dizziness, syncope, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, neutropenia, severe or life-threatening infections, life-threatening neutropenia, pancytopenia"
146,VIMIZIM,adverse reactions,"Anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue"
147,VIMIZIM,boxed warnings,"anaphylactic reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, serious acute exacerbation of respiratory compromise, hypersensitivity reactions"
148,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression, back pain, paralysis of limbs, urinary incontinence, fecal incontinence"
149,SIRTURO,adverse reactions,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased"
150,SIRTURO,boxed warnings,"Increased mortality, QT prolongation, significant ventricular arrhythmia"
151,SIRTURO,warnings and precautions,"QT prolongation, significant ventricular arrhythmia, QTcF interval > 500 ms, Hepatotoxicity, increased risk of death, Clinically significant ventricular arrhythmia, QTcF interval of greater than 500 ms, syncope, hepatic-related adverse reactions, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations accompanied by total bilirubin elevation greater than two times the upper limit of normal, aminotransferase elevations greater than eight times the upper limit of normal, aminotransferase elevations greater than five times the upper limit of normal and persist beyond two weeks"
152,NEURACEQ,adverse reactions,"erythema (1.7 %), irritation (1.2 %), pain (3.9 %)"
153,NEURACEQ,warnings and precautions,"Image interpretation errors, false positives, errors in Neuraceq estimation of brain neuritic beta-amyloid plaque density, errors from using clinical information in interpretation, errors in cases with severe brain atrophy, errors due to motion artifacts, increased risk of cancer from long-term cumulative radiation exposure"
154,COMETRIQ,adverse reactions,"Perforations and Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, fistulas, cardiac arrest, respiratory failure, unspecified death, general deterioration, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), Diarrhea, Stomatitis, Nausea, Oral pain, Constipation, Abdominal pain, Vomiting, Dysphagia, Dyspepsia, Hemorrhoids, Fatigue, Asthenia, Decreased weight, Decreased appetite, Dehydration, Arthralgia, Muscle spasms, Musculoskeletal chest pain, Dysgeusia, Headache, Dizziness, Paresthesia, Peripheral sensory neuropathy, Peripheral neuropathy, Anxiety, Dysphonia, PPES, Hair color changes/depigmentation, graying, Rash, Dry skin, Alopecia, Erythema, Hyperkeratosis, Hypotension, Increased AST, Increased ALT, Increased ALP, Hypocalcemia, Hypophosphatemia, Hyperbilirubinemia, Hypomagnesemia, Hypokalemia, Hyponatremia, Lymphopenia, Neutropenia, Thrombocytopenia, elevated blood pressure, overt hypertension"
155,COMETRIQ,boxed warnings,"Gastrointestinal perforations, fistula formation, severe hemorrhage, sometimes fatal hemorrhage, hemoptysis, gastrointestinal hemorrhage"
156,COMETRIQ,warnings and precautions,"myocardial infarction, cerebral infarction, serious arterial thromboembolic events, dehiscence, complications requiring medical intervention, hypertensive crisis, osteonecrosis of the jaw, Palmar-plantar Erythrodysesthesia syndrome (PPES), nephrotic syndrome, Reversible posterior leukoencephalopathy syndrome (RPLS), fetal harm, Gastrointestinal (GI) perforations, fistulas, fatal GI fistula, Non-GI fistulas including tracheal/esophageal, fatal Non-GI fistulas, symptoms of perforations and fistulas, Serious hemorrhage, fatal hemorrhage, Grade >=3 hemorrhagic events, recent history of hemorrhage or hemoptysis, increased incidence of thrombotic events, venous thromboembolism, arterial thromboembolism, acute myocardial infarction, clinically significant arterial thromboembolic complication, Wound complications, wound healing complications, treatment-emergent hypertension, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (modified JNC criteria) stage 1 or 2 hypertension, severe hypertension, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, persistent jaw pain, slow healing of the mouth or jaw after dental surgery, intolerable Grade 2 PPES, Grade 3-4 PPES, Proteinuria, subcortical vasogenic edema, seizures, headache, visual disturbances, confusion, altered mental function, strong CYP3A4 inducers or inhibitors, moderate or severe hepatic impairment, embryolethal in rats, increased incidences of skeletal variations in rats, visceral variations and malformations in rabbits"
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, Infections, Angioedema with concomitant use of ACE inhibitors, Oral ulceration, Renal failure, Impaired wound healing, Stomatitis, Rash, Fatigue, Diarrhea, Edema, Abdominal pain, Nausea, Fever, Asthenia, Cough, Headache, Decreased appetite, Hyperglycemia, Dyspnea, Pneumonitis, Hypercholesterolemia, Anemia, Leukopenia, Thrombocytopenia, Lymphopenia, Increased alanine transaminase (ALT), Hypertriglyceridemia, Lymphopenia, Hyperglycemia, Anemia, Decreased potassium, Increased aspartate transaminase (AST), Increased ALT, Thrombocytopenia, Acute renal failure, Acute respiratory distress, Cardiac arrest, Death (cause unknown), Hepatic failure, Pneumonia, Sepsis, Pulmonary embolism, Hypoglycemia, Myocardial infarction with congestive heart failure, Sudden death, Renal failure, Thrombotic events, Pulmonary embolus, Thrombosis, Hyperglycemia, Lymphopenia, Hypophosphatemia, Increased alkaline phosphatase, Neutropenia, Potassium decreased, Hemoglobin decreased, Hypercholesterolemia, Bicarbonate decreased, Increased aspartate transaminase (AST), Alkaline phosphatase increased, Glucose (fasting) increased, Cholesterol increased, Bicarbonate decreased, Phosphate decreased, Triglycerides increased, Calcium decreased, Potassium decreased, Creatinine increased, Sodium decreased, Bilirubin increased, Potassium increased, Acute respiratory failure, Infection, Acute renal failure, Dehydration, Abdominal pain, Asthenia, Anemia, Hypercholesterolemia, Hypertriglyceridemia, Hyperglycemia, Lymphopenia, Increased creatinine, Hypophosphatemia, Hypercholesterolemia, Amenorrhea, Hypercholesterolemia, Hypertriglyceridemia, Anemia, Hypophosphatemia, Elevated aspartate transaminase (AST), Elevated alanine transaminase (ALT), Fasting hyperglycemia, Pyrexia, Pneumonia, Gastroenteritis, Aggression, Agitation, Amenorrhea, Elevated partial thromboplastin time, Neutropenia, Hypercholesterolemia, Elevated aspartate transaminase (AST), Hypertriglyceridemia, Elevated alanine transaminase (ALT), Hypophosphatemia, Cellulitis, Hyperglycemia, Elevated creatinine, Acute pancreatitis, Cholecystitis, Cholelithiasis, Arterial thrombotic events, Reflex sympathetic dystrophy."
158,AFINITOR,warnings and precautions,"non-infectious pneumonitis, fatal cases, infections, fatal infections, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, fatal renal failure, impaired wound healing, wound-related complications, elevations of serum creatinine, urinary protein, blood glucose, lipids, decreases in hemoglobin, neutrophils, platelets, avoid live vaccines, embryo-fetal toxicity, fetal harm, pneumonia, mycobacterial infections, bacterial infections, invasive fungal infections, aspergillosis, candidiasis, pneumocystis jiroveci pneumonia (PJP), viral infections, hepatitis B virus reactivation, sepsis, respiratory failure, hepatic failure, hyperglycemia, hyperlipidemia, hypertriglyceridemia, decreased hemoglobin, lymphocytes, neutrophils, platelets, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma"
159,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism and adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, pyrexia, back pain, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, pharyngitis, rhinitis, arthralgia, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, pneumonia, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
160,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, asthma-related hospitalization"
161,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, Candida albicans infection of the mouth and pharynx, increased risk of pneumonia, worsening of infections, existing tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, more serious or fatal course of chickenpox, more serious or fatal course of measles, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia"
162,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
163,FIRAZYR,warnings and precautions,laryngeal attacks
164,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (i.e., asthenia), pancreatitis (acute or chronic), hypersensitivity-related adverse reactions (including erythema, rash, pruritus, urticaria, and angioedema), photosensitivity-related adverse reactions (including photosensitivity reaction, polymorphic light eruption, and sunburn), volume depletion-related adverse reactions (e.g., hypotension, postural dizziness, orthostatic hypotension, syncope, and dehydration), falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, phimosis, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in Low-Density Lipoprotein Cholesterol (LDL-C) and non-High-Density Lipoprotein Cholesterol (non-HDL-C), increases in hemoglobin, decreases in Bone Mineral Density (BMD)."
165,INVOKANA,warnings and precautions,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
166,VORAXAZE,adverse reactions,"Serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
167,VORAXAZE,warnings and precautions,"Serious allergic reactions, including anaphylactic reactions, Serious allergic reactions occurred in less than 1% of patients"
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
169,NESINA,warnings and precautions,"acute pancreatitis, anaphylaxis, angioedema, severe cutaneous adverse reactions, hepatic failure, hypoglycemia, severe and disabling arthralgia, Stevens-Johnson syndrome, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice"
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Influenza, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma"
171,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction, infections, Progressive multifocal leukoencephalopathy (PML), Macular edema, Posterior reversible encephalopathy syndrome (PRES), Decrease in pulmonary function tests (PFT), Liver injury, Blood pressure (BP), symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, transient AV conduction delays, first-degree AV block, second-degree AV blocks, Mobitz Types I [Wenckebach], 2:1 AV blocks, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, dose-dependent reduction in peripheral lymphocyte count, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, Cryptococcal infections, cryptococcal meningitis, blurred vision, decreased visual acuity, dose-dependent reductions in forced expiratory volume over 1 second (FEV1), diffusion lung capacity for carbon monoxide (DLCO), dyspnea, elevation of liver transaminases, nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine, hypertension"
172,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus"
173,HALAVEN,warnings and precautions,"Neutropenia, Peripheral Neuropathy, Embryo-Fetal Toxicity, QT Prolongation, Severe neutropenia, Grade 4 neutropenia, Febrile neutropenia, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, Neuropathy lasting more than one year, New or worsening neuropathy, Embryo-fetal toxicity, Teratogenicity"
174,INTELENCE,adverse reactions,"Severe skin and hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, Severe hypersensitivity reactions including DRESS, hepatic failure, rhabdomyolysis, Fatal cases of toxic epidermal necrolysis"
175,INTELENCE,warnings and precautions,"Severe skin reactions, potentially life-threatening reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 and 4 rashes, rash accompanied by fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
176,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
177,AMYVID,warnings and precautions,"Image interpretation errors, false negatives, unintentional radiation exposure, errors in Amyvid estimation of brain neuritic plaque density, errors due to extensive brain atrophy, motion artifacts, increased risk of cancer"
178,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, skin irritation, scalp irritation, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, erythema, rash, skin exfoliation, pruritus, pyoderma"
179,ULESFIA,warnings and precautions,"gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, allergic dermatitis, irritant dermatitis"
180,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, decrease appetite, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)"
181,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, loss of efficacy, depression or depressed mood, suicidal ideation and behavior, suicidal behavior, weight decrease between 5%-10% of body weight, weight decrease of >=10% of body weight"
182,ILARIS,adverse reactions,"infections predominantly of the upper respiratory tract, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, infections including intra-abdominal abscess following appendectomy, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, decreased white blood cells, decreased neutrophils, decreased platelets, elevations of transaminases, high ALT and/or AST greater than or equal to 3 times upper limit of normal, asymptomatic and mild elevations of serum bilirubin"
183,ILARIS,warnings and precautions,"increased risk of serious infections, infections, history of recurring infections, underlying conditions predisposing to infections, active infection requiring medical intervention, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, unusual or opportunistic infections, new tuberculosis, reactivation of latent tuberculosis, malignancies, hypersensitivity reactions, macrophage activation syndrome"
184,NATAZIA,adverse reactions,"Serious cardiovascular events and stroke, Vascular events, Liver disease, Irregular uterine bleeding, Nausea, Breast tenderness, Headache, Headaches, Menstrual disorders, Nausea/or vomiting, Acne, Mood changes, Increased weight, Menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding), Mood changes (depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying), Headache (including migraines), Weight increased, Breast pain, discomfort or tenderness, Menstrual disorders (metrorrhagia, menstruation irregular, menorrhagia, vaginal hemorrhage, dysfunctional uterine bleeding, genital hemorrhage, abnormal withdrawal bleeding, uterine hemorrhage), Nausea or vomiting, Acne, Mood changes (depression, mood swings, depressed mood, mood altered, affect lability, dysthymic disorder, crying), Increased weight, Myocardial infarction, Ruptured ovarian cyst, Deep vein thrombosis, Focal nodular hyperplasia of the liver, Uterine leiomyoma, Acute cholecystitis, Chronic acalculous cholecystitis, Venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction and stroke), Hypertension, Gallbladder disease, Hepatitis, Hypersensitivity, Fluid retention, Hypertriglyceridemia, Dizziness, Chloasma, Angioedema, Erythema nodosum, Erythema multiforme, Gastrointestinal symptoms (for example, abdominal pain), Vulvovaginal candidiasis"
185,NATAZIA,boxed warnings,serious cardiovascular events
186,NATAZIA,warnings and precautions,"thrombotic event, jaundice, uncontrolled hypertension, hypertension with vascular disease, significant change in headaches, irregular bleeding, amenorrhea, decreased contraceptive efficacy, venous thromboembolism (VTE), arterial thromboses, strokes, myocardial infarctions, thromboembolic disease, postpartum thromboembolism, cerebrovascular events (thrombotic and hemorrhagic strokes), unexplained loss of vision, proptosis, diplopia, papilledema, retinal vascular lesions, retinal vein thrombosis, cervical cancer, intraepithelial neoplasia, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, increased blood pressure, gallbladder disease, decreased glucose tolerance, adverse lipid changes, hypertriglyceridemia, pancreatitis, new headaches, recurrent headaches, persistent headaches, severe headaches, migraine, breakthrough bleeding, spotting, intracyclic bleeding, depression, changes in coagulation factors, changes in lipids, changes in glucose tolerance, changes in binding proteins, increased doses of thyroid hormone, exacerbation of symptoms of angioedema, chloasma"
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
188,DIFICID,warnings and precautions,"angioedema, dyspnea, pruritus, rash, hypersensitivity reactions, allergy to other macrolides"
189,ONFI,adverse reactions,"Somnolence or Sedation, Potentiation of Sedation from Concomitant Use with Central Nervous System Depressants, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior and Ideation, constipation, pyrexia, lethargy, drooling, lethargy, somnolence, ataxia, aggression, fatigue, insomnia, Vomiting, Constipation, Dysphagia, Pyrexia, Irritability, Fatigue, Upper respiratory tract infection, Pneumonia, Urinary tract infection, Bronchitis, Decreased appetite, Increased appetite, Somnolence or Sedation, Somnolence, Sedation, Lethargy, Drooling, Ataxia, Psychomotor hyperactivity, Dysarthria, Aggression, Insomnia, Cough, Anemia, eosinophilia, leukopenia, thrombocytopenia, Diplopia, vision blurred, Abdominal distention, Hypothermia, Hepatic enzyme increased, Muscle spasms, Agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, Urinary retention, Aspiration, respiratory depression, Rash, urticaria, angioedema, facial and lip edema"
190,ONFI,warnings and precautions,"Somnolence, Sedation, Withdrawal symptoms, Serious Dermatological Reactions, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Physical and Psychological Dependence, Suicidal Behavior and Ideation, Convulsions, Psychosis, Hallucinations, Behavioral disorder, Tremor, Anxiety, Dysphoria, Insomnia"
191,TECFIDERA,adverse reactions,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia"
192,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, difficulty breathing, urticaria, swelling of the throat and tongue, progressive multifocal leukoencephalopathy (PML), death, severe disability, prolonged lymphopenia, progressive weakness on one side of the body, clumsiness of limbs, disturbance of vision, changes in thinking, memory changes, orientation changes, confusion, personality changes, decrease in lymphocyte counts, infections, serious infections, flushing, warmth, redness, itching, burning sensation"
193,DYSPORT,adverse reactions,"muscular weakness, dysphagia, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, injection site reaction, breathing difficulties, dyspnea, muscle atrophy, blood glucose increase, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site numbness, injection site erythema, injection site tenderness, injection site tingling, injection site itching, injection site stinging, injection site warmth, injection site irritation, injection site tightness, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue"
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties"
195,DYSPORT,warnings and precautions,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death related to spread of toxin effects, severe dysphagia, use of a feeding tube, aspiration, critical loss of breathing capacity, respiratory failure, immediate medical attention required for problems with swallowing, speech or respiratory disorders, increased incidence of eyelid ptosis"
196,ZYTIGA,adverse reactions,"fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, hypertension, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, hypokalemia, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain or chest discomfort, cardiac failure, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis"
197,ZYTIGA,warnings and precautions,"hypertension, hypokalemia, fluid retention, increases in liver enzymes, drug interruption, dose modification, discontinuation, grade 3 to 4 hypertension, grade 3 to 4 hypokalemia, grade 3 to 4 edema, adrenal insufficiency, grade 3 or 4 ALT or AST increases, treatment discontinuation due to liver enzyme increases"
198,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, hot flush, venous thromboembolism (deep venous thrombosis, pulmonary embolism, retinal vein thrombosis)"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), unusual vaginal bleeding, heart disease, heart attacks, strokes, blood clots, dementia, cancer of the uterus (womb), breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of asthma, diabetes, epilepsy, migraines, porphyria, lupus, liver problems, new breast lumps, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
200,DUAVEE,warnings and precautions,"cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, visual abnormalities, elevated blood pressure, hypertriglyceridemia, hepatic impairment, past history of cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, exacerbation of diabetes mellitus, exacerbation of epilepsy, exacerbation of migraine, exacerbation of porphyria, exacerbation of systemic lupus erythematosus, exacerbation of hepatic hemangiomas, impaired glucose tolerance"
201,SAPHRIS,adverse reactions,"akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms other than akathisia, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, akathisia, extrapyramidal symptoms, insomnia, hypertension, dyspepsia, toothache, arthralgia, pain in extremity, headache, anxiety, depression, tachycardia, heart rate increased, glossodynia, muscle strain, hyperinsulinemia, blood insulin increased, ALT increased, AST increased, dehydration, myalgia, parkinsonism, suicidal ideation, anger, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, edema peripheral, anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, oral ulcers, blisters, peeling/sloughing, inflammation, choking"
202,SAPHRIS,boxed warnings,increased mortality in elderly patients with dementia-related psychosis
203,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, hyperglycemia, dyslipidemia, weight gain, anaphylaxis, angioedema, dizziness, tachycardia, bradycardia, syncope, leukopenia, neutropenia, agranulocytosis, QT prolongation, seizures, cognitive impairment, motor impairment, suicide, dysphagia, aspiration, orthostatic hypotension, hypotension, swollen tongue, dyspnea, wheezing, rash, hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, somnolence, body temperature regulation disruption, pyrexia, feeling hot"
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal and conjunctival hyperemia, anterior chamber flare, dry eye, iridocyclitis"
205,DUREZOL,warnings and precautions,"glaucoma, damage to the optic nerve, defects in visual acuity, defects in fields of vision, posterior subcapsular cataract formation, delayed healing, increase in the incidence of bleb formation, cornea or sclera perforations, suppression of host response, increase in the hazard of secondary ocular infections, mask infection, enhance existing infection, prolong the course of viral infections, exacerbate the severity of viral infections, fungal infections of the cornea, persistent corneal ulceration"
206,ZYDELIG,adverse reactions,"Hepatotoxicity, Severe Diarrhea or Colitis, Pneumonitis, Intestinal Perforation, Severe Cutaneous Reactions, Anaphylaxis, Neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, neutropenia, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, pneumonia, pyrexia, sepsis, febrile neutropenia, diarrhea, elevated transaminases, nausea, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, GGT increased, triglycerides (hypertriglyceridemia), hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
207,ZYDELIG,boxed warnings,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation"
208,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, elevations in ALT or AST, diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, serious allergic reactions, treatment-emergent Grade 3 or 4 neutropenia"
209,KALBITOR,adverse reactions,"Hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, erythema, pain, irritation, urticaria, bruising"
210,KALBITOR,boxed warnings,Anaphylaxis
211,KALBITOR,warnings and precautions,"anaphylaxis, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
212,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, Lymphadenopathy, Headache, Dizziness, Chills, Pain, Edema peripheral, Abdominal pain, Constipation, Pruritus, Alopecia, Night sweats, Dry skin, Dyspnea, Oropharyngeal pain, Arthralgia, Myalgia, Back pain, Pain in extremity, Muscle spasms, Insomnia, Anxiety, Decreased appetite, Weight decreased, febrile neutropenia, hyperglycemia, Pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, Toxic epidermal necrolysis, peripheral motor neuropathy, pulmonary embolism, pneumonitis, pneumothorax, pyelonephritis, septic shock, supraventricular arrhythmia, urinary tract infection, PML, Stevens-Johnson syndrome"
213,ADCETRIS,boxed warnings,"Progressive multifocal leukoencephalopathy (PML), death"
214,ADCETRIS,warnings and precautions,"Peripheral neuropathy, neuropathic pain, weakness, anaphylaxis, infusion reactions, neutropenia, thrombocytopenia, anemia, febrile neutropenia, pneumonia, bacteremia, sepsis, septic shock, tumor lysis syndrome, hepatotoxicity, progressive multifocal leukoencephalopathy (PML), pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), fetal harm, embryo-fetal toxicities, fetal malformations"
215,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"overgrowth of non-susceptible organisms including fungi, super-infection"
217,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation"
218,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbate heart failure, rebound hypertension"
219,XTANDI,adverse reactions,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections or sepsis resulting in death, fall-related injuries, hypertensive crisis"
220,XTANDI,warnings and precautions,seizure
221,BOSULIF,adverse reactions,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, Diarrhea, Nausea, Thrombocytopenia, Vomiting, Abdominal pain, Rash, Anemia, Pyrexia, Fatigue, Anaphylactic shock, Increased alanine aminotransferase, Headache, Cough, Increased aspartate aminotransferase, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval of greater than 500 milliseconds, Platelet Count (Low), Absolute Neutrophil Count (Low), Hemoglobin (Low), SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, Lipase greater than 2*ULN, Phosphorus (Low), Total Bilirubin greater than 3.0*ULN, Febrile neutropenia, Pericardial effusion, Pericarditis, Tinnitus, Gastritis, Acute pancreatitis, Gastrointestinal hemorrhage, Chest pain, Pain, Hepatotoxicity, Abnormal hepatic function, Liver injury, Drug hypersensitivity, Pneumonia, Influenza, Bronchitis, Electrocardiogram QT prolonged, Increased blood creatine phosphokinase, Increased blood creatinine, Hyperkalemia, Dehydration, Myalgia, Dysgeusia, Acute renal failure, Renal failure, Pleural effusion, Acute pulmonary edema, Respiratory failure, Pulmonary hypertension, Urticaria, Acne, Erythema multiforme, Exfoliative rash, Drug eruption"
222,BOSULIF,warnings and precautions,"Diarrhea, nausea, vomiting, abdominal pain, thrombocytopenia, anemia, neutropenia, drug induced liver injury, ALT elevation, AST elevation, pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, decline in estimated glomerular filtration rate (eGFR), embryofetal toxicities"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
224,CARBAGLU,warnings and precautions,"Hyperammonemia, injury to the brain, death, acute symptomatic hyperammonemia, dialysis, hemodialysis, brain injury/damage, protein restriction"
225,SIMPONI,adverse reactions,"Serious Infections, Malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, administration reactions, immunogenicity, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, melanoma, serious systemic hypersensitivity reactions, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions"
226,SIMPONI,boxed warnings,"serious infections leading to hospitalization or death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, lymphoma, malignancies, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, disseminated disease, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella infections, Listeria infections"
227,SIMPONI,warnings and precautions,"Serious infections, Invasive fungal infections, Hepatitis B reactivation, Malignancies, Heart failure, Demyelinating disease, Hypersensitivity reactions, Opportunistic infections (aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis), Tuberculosis reactivation, New tuberculosis infections, Hepatosplenic T-cell lymphoma, Melanoma, Merkel cell carcinoma, Worsening congestive heart failure, New onset congestive heart failure, New onset or exacerbation of central nervous system demyelinating disorders, Multiple sclerosis, Peripheral demyelinating disorders, Guillain-Barre syndrome, Central demyelination, Optic neuritis, Peripheral demyelinating polyneuropathy, Pancytopenia, Leukopenia, Neutropenia, Aplastic anemia, Thrombocytopenia, Serious systemic hypersensitivity reactions, Anaphylactic reaction"
228,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions including Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, mild infusion reactions of nausea, erythematous rash, pruritus, eyelid edema, headache, dyspnea, Fatal anaphylaxis"
229,BENLYSTA,warnings and precautions,"mortality, serious infections, fatal infections, Progressive Multifocal Leukoencephalopathy (PML), hypersensitivity reactions, anaphylaxis, fatal reactions, depression, suicidality, worsening depression, suicidal thoughts, mood changes, upper respiratory tract infection, urinary tract infection, nasopharyngitis, sinusitis, bronchitis, influenza, pneumonia, cellulitis, infections leading to discontinuation of treatment, infections resulting in death, neurological deficits, malignancies, non-melanoma skin cancers, rash, nausea, fatigue, myalgia, headache, facial edema, hypotension, angioedema, urticaria, pruritus, dyspnea, infusion reactions, bradycardia, skin reactions, psychiatric events, insomnia, anxiety, serious psychiatric events, serious depression, suicides"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus"
231,TOVIAZ,warnings and precautions,"Angioedema of the face, lips, tongue, and/or larynx, urinary retention, severe constipation, headache, dizziness, somnolence"
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,myocardial infarction
234,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea and vomiting, diarrhea, serious adverse reactions in patients with severe hepatic impairment, serious adverse reactions in patients with complete gastrointestinal obstruction, serious adverse reactions in pancreatic and gastric anastomoses"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction with flushing, dyspnea, chest pressure"
236,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, radiation risk, increased risk of cancer"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state"
238,AMPYRA,warnings and precautions,"seizures, anaphylaxis, respiratory compromise, urticaria, angioedema of the throat and or tongue, urinary tract infections"
239,ADCETRIS,all-concat,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity including pneumonitis, interstitial lung disease, ARDS, Toxic epidermal necrolysis"
240,ADREVIEW,all-concat,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, benzyl alcohol toxicity (hypotension, metabolic acidosis), kernicterus, increased radiation exposure, thyroid neoplasia, hypertension"
241,AFINITOR,all-concat,"Non-infectious pneumonitis, Infections, Angioedema with concomitant use of ACE inhibitors, Oral ulceration, Renal failure, Impaired wound healing, Stomatitis, Rash, Fatigue, Diarrhea, Edema, Abdominal pain, Nausea, Fever, Asthenia, Cough, Headache, Decreased appetite, Hyperglycemia, Dyspnea, Hypercholesterolemia, Anemia, Leukopenia, Thrombocytopenia, Lymphopenia, Increased alanine transaminase (ALT), Hypertriglyceridemia, Lymphopenia, Hyperglycemia, Anemia, Decreased potassium, Increased aspartate transaminase (AST), Increased ALT, Thrombocytopenia, Acute renal failure, Acute respiratory distress, Cardiac arrest, Death (cause unknown), Hepatic failure, Pneumonia, Sepsis, Pulmonary embolism, Hypoglycemia, Myocardial infarction with congestive heart failure, Sudden death, Thrombotic events, Pulmonary embolus, Thrombosis, Gastrointestinal disorders, Nausea, Vomiting, Constipation, Dry mouth, General disorders and administration site conditions, Infections and infestations, Weight decreased, Metabolism and nutrition disorders, Hyperglycemia, Musculoskeletal and connective tissue disorders, Arthralgia, Back pain, Pain in extremity, Nervous system disorders, Dysgeusia, Headache, Psychiatric disorders, Insomnia, Respiratory, thoracic and mediastinal disorders, Dyspnea, Epistaxis, Pneumonitis, Skin and subcutaneous tissue disorders, Pruritus, Alopecia, Vascular disorders, Hot flush, Hemoglobin decreased, WBC decreased, Platelets decreased, Lymphocytes decreased, Neutrophils decreased, Glucose increased, Cholesterol increased, Aspartate transaminase (AST) increased, Alanine transaminase (ALT) increased, Triglycerides increased, Albumin decreased, Potassium decreased, Creatinine increased, Amenorrhea, Menorrhagia, Menstrual irregularities, Vaginal hemorrhage, Epistaxis, Decreased appetite, Otitis media, Depression, Abnormal taste, Increased blood luteinizing hormone (LH) levels, Increased blood follicle stimulating hormone (FSH) levels, Hypersensitivity, Ovarian cyst, Pneumonitis, Angioedema, Elevated partial thromboplastin time, Neutropenia, Hypercholesterolemia, Elevated aspartate transaminase (AST), Hypertriglyceridemia, Elevated alanine transaminase (ALT), Hypophosphatemia, Cellulitis, Hyperglycemia, Elevated creatinine, Acute pancreatitis, Cholecystitis, Cholelithiasis, Arterial thrombotic events, Reflex sympathetic dystrophy"
242,AMPYRA,all-concat,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state"
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
244,APTIOM,all-concat,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions and Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, ear and labyrinth disorders, eye disorders, gastrointestinal disorders, general disorders and administration site conditions, infections and infestations, injury, poisoning and procedural complications, metabolism and nutrition disorders, nervous system disorders, psychiatric disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, vascular disorders, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, fever, rash, lymphadenopathy, laryngeal edema, seizures, severe nausea/vomiting, dehydration, severe gait instability, injury, hypochloremia, disturbance in gait and coordination, balance disorder, gait disturbance, nystagmus, abnormal coordination, depression, insomnia, cough, hypertension, cognitive dysfunction, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, visual impairment, asthenia, gait disturbance, peripheral edema, urinary tract infections, fall, hyponatremia, balance disorder, dysarthria, memory impairment, nystagmus, depression, insomnia, cough, rash, hypertension"
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness"
246,BELEODAQ,all-concat,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, Constipation, Diarrhea, Dyspnea, Rash, Peripheral Edema, Cough, Thrombocytopenia, Pruritus, Chills, Increased Blood Lactate Dehydrogenase, Decreased Appetite, Headache, Infusion Site Pain, Hypokalemia, Prolonged QT, Abdominal pain, Hypotension, Phlebitis, Dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation, febrile neutropenia, leukopenia (neutropenia and lymphopenia), sepsis, liver function test abnormalities, teratogenicity, embryo-fetal lethality"
247,BENLYSTA,all-concat,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions including Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, gastroenteritis viral, Fatal anaphylaxis, Progressive Multifocal Leukoencephalopathy (PML), upper respiratory tract infection, urinary tract infection, sinusitis, influenza, pneumonia, cellulitis, erythematous rash, pruritus, eyelid edema, headache, dyspnea, cardiovascular disease, suicide, rash, fatigue, myalgia, facial edema, hypotension, angioedema, urticaria, bradycardia, anxiety"
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, itching, body rash, swelling of lips, tongue and/or throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache, overgrowth of non-susceptible organisms including fungi"
250,BLINCYTO,all-concat,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm"
251,BOSULIF,all-concat,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, Diarrhea, Nausea, Thrombocytopenia, Vomiting, Abdominal pain, Rash, Anemia, Pyrexia, Fatigue, Anaphylactic shock, Increased alanine aminotransferase, Headache, Cough, Increased aspartate aminotransferase, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval of greater than 500 milliseconds, Platelet Count (Low), Absolute Neutrophil Count (Low), Hemoglobin (Low), SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, Lipase greater than 2*ULN, Phosphorus (Low), Total Bilirubin greater than 3.0*ULN, Febrile neutropenia, Pericardial effusion, Pericarditis, Tinnitus, Gastritis, Acute pancreatitis, Gastrointestinal hemorrhage, Chest pain, Hepatotoxicity, Abnormal hepatic function, Liver injury, Drug hypersensitivity, Pneumonia, Influenza, Bronchitis, Electrocardiogram QT prolonged, Increased blood creatine phosphokinase, Increased blood creatinine, Hyperkalemia, Dehydration, Myalgia, Dysgeusia, Acute renal failure, Renal failure, Pleural effusion, Acute pulmonary edema, Respiratory failure, Pulmonary hypertension, Urticaria, Acne, Erythema multiforme, Exfoliative rash, Drug eruption"
252,BREO,all-concat,"asthma-related death, asthma-related hospitalization, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, pyrexia, back pain, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, pharyngitis, rhinitis, arthralgia, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, pneumonia, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
253,CARBAGLU,all-concat,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, brain injury/damage, death"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, cardiac arrhythmias"
255,CHOLINE,all-concat,"mild injection site reaction, Imaging errors, allergic reactions, anaphylaxis, increased risk for cancer"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, Serious Infections, Malignancies, Heart Failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, Anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, Angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, Optic neuritis, retinal hemorrhage, uveitis, Bleeding, injection site reactions, Elevated liver enzymes, hepatitis, Alopecia totalis, Anxiety, bipolar disorder, suicide attempt, Nephrotic syndrome, renal failure, Menstrual disorder, Dermatitis, erythema nodosum, Thrombophlebitis, vasculitis, Headache, Hypertension, Back pain, Pharyngitis, Acute bronchitis, Fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, lupus-like syndrome, Hepatitis B virus reactivation, Demyelinating disease, Cytopenias, Anaphylaxis or serious allergic reactions, Neurologic Reactions, Hematological Reactions, hepatosplenic T-cell lymphoma, acute and chronic leukemia"
257,CLEVIPREX,all-concat,"headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, hypotension, decreased oxygen saturation, reflex tachycardia"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption), QT prolongation"
259,COMETRIQ,all-concat,"Perforations and Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, fistulas, cardiac arrest, respiratory failure, unspecified death, general deterioration, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), Gastrointestinal perforations, fistula formation, hemorrhage, hemoptysis, gastrointestinal hemorrhage, myocardial infarction, cerebral infarction, arterial thromboembolic events, dehiscence, hypertensive crisis, nephrotic syndrome, embryofetal toxicity, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, persistent jaw pain, slow healing of the mouth or jaw after dental surgery, intolerable Grade 2 PPES, Grade 3-4 PPES, subcortical vasogenic edema, seizures, headache, visual disturbances, confusion, altered mental function, embryolethal, skeletal variations, visceral variations, malformations"
260,DALVANCE,all-concat,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, serious hypersensitivity (anaphylactic) and skin reactions, ""Red-Man Syndrome"""
261,DATSCAN,all-concat,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, skin erythema, injection site pain"
262,DIFICID,all-concat,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions (dyspnea, angioedema, rash, pruritus)"
263,DOTAREM,all-concat,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions (including site inflammation, extravasation, pruritus, and warmth), bradycardia, tachycardia, arrhythmia, anaphylactoid reactions (including cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria), coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
264,DUAVEE,all-concat,"muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, hot flush, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), gallbladder disease, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of asthma, diabetes, epilepsy, migraines, genetic problem called porphyria, lupus, liver problems, breast lumps, unusual vaginal bleeding, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, blood clots, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems such as asthma, diabetes, epilepsy, migraines, a genetic problem called porphyria, lupus, liver problems, retinal vascular thrombosis, pancreatitis, hypocalcemia, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance"
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal and conjunctival hyperemia, anterior chamber flare, dry eye, iridocyclitis, glaucoma, defects in visual acuity and fields of vision, posterior subcapsular cataract formation, delayed healing, bleb formation, bacterial infections, viral infections, fungal infections"
266,DYSPORT,all-concat,"muscular weakness, dysphagia, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, breathing difficulties, dyspnea, muscle atrophy, blood glucose increase, heart rate reduction, injection site bruising, injection site reaction (numbness, discomfort, erythema, tenderness, tingling, itching, stinging, warmth, irritation, tightness, swelling), bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, blood present in urine, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, fatigue, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphonia, dysarthria, urinary incontinence"
267,EDARBI,all-concat,"diarrhea, hypotension/orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, high markedly abnormal platelet counts, high markedly abnormal WBC counts, rash, pruritus, angioedema, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension (neonatal), renal failure (neonatal), death (neonatal), symptomatic hypotension, oliguria, progressive azotemia, acute renal failure"
268,ELIQUIS,all-concat,"Increased risk of thrombotic events after premature discontinuation, Bleeding, Spinal/epidural anesthesia or puncture, Intracranial bleed, Hemorrhagic stroke, Gastrointestinal (GI) bleed, Fatal bleeding, Intracranial, Non-intracranial, Hypersensitivity reactions, Syncope, Nausea, Anemia, Contusion, Hemorrhage, Postprocedural hemorrhage, Transaminases increased, Aspartate aminotransferase increased, Gamma-glutamyltransferase increased, Thrombocytopenia, Hypotension, Epistaxis, Gastrointestinal hemorrhage, Hematochezia, Liver function test abnormal, Blood alkaline phosphatase increased, Blood bilirubin increased, Hematuria, Wound secretion, Incision-site hemorrhage, Operative hemorrhage, Gingival bleeding, Hemoptysis, Muscle hemorrhage, Ocular hemorrhage, Rectal hemorrhage, Hemorrhagic anemia, Hemorrhoidal hemorrhage, Hematemesis, Melena, Anal hemorrhage, Wound hemorrhage, Postprocedural hemorrhage, Traumatic hematoma, Periorbital hematoma, Vaginal hemorrhage, Metrorrhagia, Menometrorrhagia, Genital hemorrhage, Hemorrhage, Ecchymosis, Skin hemorrhage, Petechiae, Conjunctival hemorrhage, Retinal hemorrhage, Eye hemorrhage, Blood urine present, Occult blood positive, Red blood cells urine positive, Injection-site hematoma, Vessel puncture-site hematoma"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea and vomiting, diarrhea"
270,EOVIST,all-concat,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, Nausea, Headache, Feeling hot, Dizziness, Back pain, Vomiting, Blood pressure increased, Injection site reactions (pain, burning, coldness, extravasation, irritation), Dysgeusia, Paresthesia, Flushing, Parosmia, Pruritus (generalized, eye), Rash, Respiratory disorders (dyspnea, respiratory distress), Fatigue, Chest pain, Vertigo, Dry mouth, Chills, Feeling abnormal, Tremor, Akathisia, Bundle branch block, Palpitation, Oral discomfort, Salivary hypersecretion, Maculopapular rash, Hyperhidrosis, Discomfort, Malaise, Elevation of serum iron values, Serum bilirubin laboratory values, Anaphylactic shock, Hypotension, Pharyngolaryngeal edema, Urticaria, Face edema, Rhinitis, Conjunctivitis, Abdominal pain, Hypoesthesia, Sneezing, Cough, Pallor, Tachycardia, Restlessness"
271,ERWINAZE,all-concat,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperlipidemia, ketoacidosis, CNS events, cerebral venous thrombosis, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
272,EYLEA,all-concat,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear"
273,FANAPT,all-concat,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure (including congestive and acute), vertigo, tinnitus, hypothyroidism, conjunctivitis (including allergic), dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia (including conjunctival), gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema (general, pitting, due to cardiac disease), difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, restlessness, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, increased mortality in elderly patients with dementia-related psychosis, cerebrovascular adverse events including stroke, QT prolongation, arrhythmia, sudden death, neuroleptic malignant syndrome, tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, weight gain, seizures, syncope, leukopenia, neutropenia, agranulocytosis, hyperprolactinemia, body temperature regulation disruption, dysphagia, suicide risk, priapism, cognitive and motor impairment."
274,FARXIGA,all-concat,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Female genital mycotic infections, Nasopharyngitis, Urinary tract infections, Back pain, Increased urination, Male genital mycotic infections, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with urination, Pain in extremity, Volume Depletion, Dehydration, Hypovolemia, Orthostatic hypotension, Increases in serum creatinine, Decreases in eGFR, Renal failure, Blood creatinine increase, Bone fractures, Hypersensitivity reactions, Angioedema, Urticaria, Increase in Hematocrit, Increase in Serum Inorganic Phosphorus, Hyperphosphatemia"
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
277,FULYZAQ,all-concat,"Upper respiratory tract infection, Bronchitis, Cough, Flatulence, Increased bilirubin, Nausea, Back pain, Arthralgia, Urinary tract infection, Nasopharyngitis, Musculoskeletal pain, Hemorrhoids, Giardiasis, Anxiety, Increased alanine aminotransferase, Abdominal distension, Abdominal pain, Acne, Increased aspartate aminotransferase, Increased conjugated bilirubin, Increased unconjugated blood bilirubin, Constipation, Depression, Dermatitis, Dizziness, Dry mouth, Dyspepsia, Gastroenteritis, Herpes zoster, Nephrolithiasis, Pain in extremity, Pollakiuria, Procedural pain, Seasonal allergy, Sinusitis, Decreased white blood cell count"
278,GADAVIST,all-concat,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash (includes generalized, macular, papular, pruritic), Pruritus (includes generalized), Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, acute kidney injury"
279,GILENYA,all-concat,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Influenza, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic and hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma, bradycardia, hypotension, fatigue, palpitations, chest pain, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, bronchitis, herpes simplex encephalitis, disseminated varicella zoster, multiorgan failure, cryptococcal meningitis, decrease in pulmonary function tests, elevation of liver transaminases"
280,GILOTRIF,all-concat,"Diarrhea, Bullous and Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction (diastolic dysfunction, left ventricular dysfunction, ventricular dilation), Cheilitis, Cystitis, Epistaxis, Rhinorrhea, Weight Decreased, Pyrexia, Conjunctivitis, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis, renal failure, dehydration, bullous, blistering, exfoliating lesions, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, liver test abnormalities, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, embryotoxic, abortions"
281,GRANIX,all-concat,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria"
282,HALAVEN,all-concat,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, embryo-fetal toxicity"
283,HORIZANT,all-concat,"Somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, fatigue/asthenia, insomnia, breast enlargement, gynecomastia, elevated creatine kinase"
284,ILARIS,all-concat,"infections predominantly of the upper respiratory tract, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, intra-abdominal abscess following appendectomy, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, tonsillitis, sinusitis, urinary tract infection, viral infection, abdominal pain (upper), mild injection site reaction, moderate injection site reaction, hypersensitivity reactions, decreased white blood cells, neutrophils and platelets, decreased white blood cell counts, transient decreases in absolute neutrophil count, mild and transient decreases in platelet counts, elevations of transaminases, high ALT and/or AST, asymptomatic and mild elevations of serum bilirubin, increased risk of serious infections, unusual or opportunistic infections (e.g., aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster), increased risk of new tuberculosis and reactivation of latent tuberculosis, increase in the risk of malignancies"
285,IMBRUVICA,all-concat,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, stomatitis, dyspepsia, urinary tract infection, sinusitis, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, renal failure, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, oropharyngeal pain, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, progressive multifocal leukoencephalopathy (PML)"
286,INLYTA,all-concat,"diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia (hand-foot) syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes (absolute) decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia, hypertensive crisis, arterial thromboembolic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula formation, reversible posterior leukoencephalopathy syndrome (RPLS), elevation of liver enzymes, hepatic impairment, fetal harm"
287,INTELENCE,all-concat,"Severe skin and hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, severe hypersensitivity reactions including DRESS, hepatic failure, rhabdomyolysis, fatal cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), redistribution/accumulation of body fat including central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, autoimmune disorders such as Graves' disease, polymyositis, Guillain-Barre syndrome"
288,INVOKANA,all-concat,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (i.e., asthenia), pancreatitis (acute or chronic), erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, vulvovaginal mycotic infection, vulvovaginal candidiasis, vulvovaginitis, candidal balanitis, balanoposthitis, phimosis, increases in serum potassium, severe elevations in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in Low-Density Lipoprotein Cholesterol (LDL-C) and non-High-Density Lipoprotein Cholesterol (non-HDL-C), increases in hemoglobin, decreases in Bone Mineral Density (BMD)"
289,JARDIANCE,all-concat,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), urinary tract infections, female genital mycotic infections, upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, nausea, thirst (including polydipsia), volume depletion (e.g., blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypotension, hypovolemia, orthostatic hypotension, syncope), increased urination (e.g., polyuria, pollakiuria, nocturia), increases in serum creatinine, decreases in eGFR, hypoglycemia, genital mycotic infections (e.g., vaginal mycotic infection, vaginal infection, genital infection fungal, vulvovaginal candidiasis, vulvitis), phimosis, urinary tract infections (e.g., urinary tract infection, asymptomatic bacteriuria, cystitis), increase in low-density lipoprotein cholesterol (LDL-C), increase in hematocrit"
290,JEVTANA,all-concat,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, Arrhythmia, Dyspepsia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, Gastritis, intestinal obstruction, neutropenic deaths, generalized rash/erythema, bronchospasm, neutropenic infections, sepsis, septic shock, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, ileus, enterocolitis, increased AST, increased ALT, increased bilirubin"
291,JUBLIA,all-concat,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, local pruritus, erythema, pain, irritation, urticaria, bruising, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, wheezing, hypotension, rash"
293,KALYDECO,all-concat,"headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, aspartate aminotransferase increased, bacteria in sputum, blood glucose increased, hepatic enzyme increased, arthralgia, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, transaminase elevations, elevated liver transaminases, non-congenital lens opacities/cataracts"
294,KYPROLIS,all-concat,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity and Hepatic Failure, Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, constipation, asthenia, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, peripheral neuropathies NEC, insomnia, rash, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, dizziness, epistaxis, hepatic failure, musculoskeletal chest pain, embolic and thrombotic events, venous (including deep vein thrombosis and pulmonary embolism)."
295,LUMIZYME,all-concat,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, angioedema, throat tightness, chest pain/discomfort, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, edema, peripheral, rash papular, flu-like illness, arthralgia, pain"
296,MULTAQ,all-concat,"diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, QT prolongation, dyspeptic signs and symptoms, asthenic conditions, bradycardia, rashes (generalized, macular, maculo-papular, erythematous), pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine >=10%, QTc prolonged, new or worsening heart failure, atrial flutter with 1:1 atrioventricular conduction, liver injury, interstitial lung disease including pneumonitis and pulmonary fibrosis, anaphylactic reactions including angioedema, vasculitis, including leukocytoclastic vasculitis, increased risk of death, stroke, hepatocellular liver injury, acute liver failure requiring transplant, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, small increases in creatinine levels"
297,NATAZIA,all-concat,"Serious cardiovascular events and stroke, Vascular events, Liver disease, Irregular uterine bleeding, Nausea, Breast tenderness, Headache, Headaches, Irregular uterine bleeding, Headache (including migraines) 13%, Breast tenderness, Pain 7%, Menstrual disorders 7%, Nausea/ or vomiting 6%, Acne 4%, Mood changes 3%, Increased weight 3%, Menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding) 2.3%, Mood changes (depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying) 1.2%, Acne 1.1%, Headache (including migraines) 1.1%, Weight increased 0.7%, Headache (including migraines) 12.7%, Breast pain, discomfort or tenderness 7.0%, Menstrual disorders (metrorrhagia, menstruation irregular, menorrhagia, vaginal hemorrhage, dysfunctional uterine bleeding, genital hemorrhage, abnormal withdrawal bleeding, uterine hemorrhage) 6.9%, Nausea or vomiting 6.0%, Acne 3.9%, Mood changes (depression, mood swings, depressed mood, mood altered, affect lability, dysthymic disorder, crying) 3.0%, Increased weight 2.9%, Myocardial infarction, Ruptured ovarian cyst, Deep vein thrombosis, Focal nodular hyperplasia of the liver, Uterine leiomyoma, Acute cholecystitis, Chronic acalculous cholecystitis, Venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction and stroke), Hypertension, Gallbladder disease, Hepatitis, Hypersensitivity, Fluid retention, Hypertriglyceridemia, Dizziness, Chloasma, Angioedema, Erythema nodosum, Erythema multiforme, Gastrointestinal symptoms (for example, abdominal pain), Vulvovaginal candidiasis"
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
299,NEURACEQ,all-concat,"injection site reaction consisting of erythema (1.7 %), irritation (1.2 %), pain (3.9 %), Image interpretation errors, unintentional radiation exposure, increased risk of cancer"
300,NORTHERA,all-concat,"Supine Hypertension, Hyperpyrexia, Confusion, exacerbate existing ischemic heart disease, arrhythmias, congestive heart failure, Headache, Dizziness, Nausea, Hypertension, Fatigue, falls, urinary tract infections, syncope, allergic reactions"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion-related reactions, hypotension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
302,ONFI,all-concat,"constipation, somnolence or sedation, pyrexia, lethargy, drooling, vomiting, dysphagia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, somnolence, sedation, drooling, ataxia, psychomotor hyperactivity, dysarthria, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial and lip edema, Stevens-Johnson syndrome, toxic epidermal necrolysis, withdrawal symptoms, convulsions, psychosis, hallucinations, behavioral disorder, tremor, suicidal thoughts or behavior, depression"
303,OTEZLA,all-concat,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound), suicidal thoughts, suicidal behavior, suicidal ideation"
304,PICATO,all-concat,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis"
305,POTIGA,all-concat,"Retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior and ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
306,PRADAXA,all-concat,"bleeding, gastritis-like symptoms, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, major bleeding, decrease in hemoglobin, transfusion of >=2 units of packed red blood cells, bleeding at a critical site, fatal outcome, intracranial hemorrhage, intracerebral hemorrhage, hemorrhagic stroke, subarachnoid bleed, subdural bleed, gastrointestinal bleed, fatal bleeding, non-intracranial fatal bleed, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding in a critical area or organ, intraocular bleed, intraspinal bleed, intramuscular with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, angioedema, thrombocytopenia, esophageal ulcer, spinal/epidural hematoma, thrombotic events, myocardial infarction, abdominal pain upper, abdominal discomfort, epigastric discomfort, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer"
307,PRISTIQ,all-concat,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease and Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, headache, vomiting, fatigue, chills, feeling jittery, tremor, disturbance in attention, nervousness, abnormal dreams, urinary hesitation, yawning, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, Stevens-Johnson syndrome, proteinuria, orthostatic hypotension"
308,PROLIA,all-concat,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, pancreatitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, cataracts, drug-related hypersensitivity reactions, anaphylaxis, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, marked elevation in serum PTH, new malignancies"
309,PROMACTA,all-concat,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, serum liver test abnormalities, portal vein thromboses, abdominal pain, toothache, vitamin D deficiency, hyperbilirubinemia, total bilirubin greater than or equal to 1.5 x ULN, ALT or AST greater than or equal to 3 x ULN, pain in extremity, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, cytogenetic abnormality, Thrombotic microangiopathy with acute renal failure, ascites, encephalopathy, indirect hyperbilirubinemia, thrombotic event, abdominal pain, nausea, vomiting, diarrhea"
310,QUTENZA,all-concat,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor, inhalation of airborne capsaicin resulting in coughing or sneezing, irritation of eyes or airways, transient increases in blood pressure, procedural pain"
311,SAPHRIS,all-concat,"akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms other than akathisia, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, increased weight, akathisia, extrapyramidal symptoms (excluding akathisia), insomnia, hypertension, anxiety, oral hypoesthesia, toothache, arthralgia, pain in extremity, headache, other extrapyramidal symptoms (excluding akathisia), depression, tachycardia, oral paraesthesia, glossodynia, irritability, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, somnolence, dizziness, dysgeusia, akathisia, parkinsonism, insomnia, suicidal ideation, anger, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, oral ulcers, blisters, peeling/sloughing, inflammation, choking, cerebrovascular adverse events (e.g., stroke, transient ischemic attack), hyperglycemia, dyslipidemia, body weight gain, hypotension, tachycardia, bradycardia, syncope, leukopenia, neutropenia, agranulocytosis, QT prolongation, seizures, cognitive and motor impairment, body temperature regulation, dysphagia"
312,SIMPONI,all-concat,"upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, malignancy, lymphoma, non-melanoma skin cancer (NMSC), liver enzyme elevations, autoimmune disorders, autoantibodies, lupus-like syndrome, infusion reaction, immunogenicity, pyrexia, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, melanoma, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions, hepatitis B reactivation, heart failure, demyelinating disease, central nervous system demyelinating disorders, multiple sclerosis, peripheral demyelinating disorders, Guillain-Barre syndrome, pancytopenia, aplastic anemia, thrombocytopenia"
313,SIRTURO,all-concat,"Increased mortality, QT Prolongation, Hepatotoxicity, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, aminotransferase elevations, Clinically significant ventricular arrhythmia, QTcF interval of greater than 500 ms"
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, upper respiratory infection, electrocardiogram abnormal, dizziness, gastroenteritis viral, Non-arteritic anterior ischemic optic neuropathy (NAION), priapism"
315,STRIBILD,all-concat,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, Nausea, Diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, Suicidal ideation, Suicide attempt, Depression, Abdominal pain, Dyspepsia, Vomiting, Fever, Pain, Nasopharyngitis, Pneumonia, Sinusitis, Upper respiratory tract infection, Arthralgia, Back pain, Myalgia, Paresthesia, Peripheral neuropathy, Anxiety, Increased cough, Rhinitis, Skin discoloration, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Urine RBC (Hematuria), Proteinuria, Serum creatinine increase, Estimated creatinine clearance decrease, Allergic reaction, Angioedema, Lactic acidosis, Hypokalemia, Hypophosphatemia, Dyspnea, Pancreatitis, Increased amylase, Hepatic steatosis, Hepatitis, Increased liver enzymes, Rhabdomyolysis, Osteomalacia, Muscular weakness, Myopathy, Acute renal failure, Renal failure, Acute tubular necrosis, Fanconi syndrome, Proximal renal tubulopathy, Interstitial nephritis, Nephrogenic diabetes insipidus, Renal insufficiency, Polyuria, Asthenia"
316,TAFINLAR,all-concat,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, cuSCC, cough, constipation, nasopharyngitis, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, hyperglycemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT Prolongation, retinal vein occlusion, interstitial lung disease, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, KRAS mutation-positive pancreatic adenocarcinoma, recurrent NRAS mutation-positive colorectal carcinoma, head and neck carcinoma, glioblastoma, RPED, uveitis, iritis"
317,TANZEUM,all-concat,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, gamma glutamyltransferase (GGT) increase, heart rate increase"
318,TECFIDERA,all-concat,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, Abdominal pain, Diarrhea, Nausea, Vomiting, Pruritus, Rash, Albumin urine present, Erythema, Dyspepsia, Aspartate aminotransferase increased, Eosinophilia"
319,TEFLARO,all-concat,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
320,TIVICAY,all-concat,"Hypersensitivity reactions, Effects on serum liver biochemistries in patients with hepatitis B or C co-infection, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, Treatment-emergent Adverse Drug Reactions, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, or completion, renal impairment, pruritus, ALT abnormalities, AST abnormalities, creatine kinase abnormalities, hyperglycemia, lipase abnormalities, total neutrophils abnormalities, cholesterol increase, HDL cholesterol increase, LDL cholesterol increase, triglycerides increase, elevated total bilirubin, worsening or development of transaminase elevations, Redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to indolent or residual opportunistic infections, autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barre syndrome)."
321,TOVIAZ,all-concat,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus"
322,TREANDA,all-concat,"Myelosuppression, Infections, Anaphylaxis and Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, worsening hypertension, hypertensive crisis, hypersensitivity, chills, nasopharyngitis, infection, herpes simplex, hyperuricemia, pruritus, hemoglobin decreased, platelets decreased, leukocytes decreased, lymphocytes decreased, neutrophils decreased, bilirubin elevations, increased AST, increased ALT, creatinine levels changes, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, weight decreased, anorexia, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, cough, dyspnea, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, hypotension, neutropenic sepsis, diffuse alveolar hemorrhage, opportunistic infection (CMV), septic shock, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, injection or infusion site reactions including phlebitis, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, SJS, TEN"
323,TRULICITY,all-concat,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, systemic hypersensitivity reactions, injection-site reactions, PR interval prolongation, first degree AV block, amylase increase, lipase increase"
324,TUDORZA,all-concat,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, skin irritation, scalp irritation, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, erythema, rash, skin exfoliation, gasping syndrome, eye irritation, contact dermatitis"
326,ULORIC,all-concat,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, gout flare, cardiovascular thromboembolic events"
327,VICTRELIS,all-concat,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, diarrhea, vomiting, dry mouth, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
328,VIMIZIM,all-concat,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, anti-drug antibodies, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, retching, peripheral edema, acute respiratory illness, serious acute exacerbation of respiratory compromise, spinal or cervical cord compression, back pain, paralysis of limbs, urinary incontinence, fecal incontinence"
329,VIZAMYL,all-concat,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, hypersensitivity reactions, image interpretation errors, radiation risk"
330,VORAXAZE,all-concat,"Serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction and failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
331,XALKORI,all-concat,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, Electrocardiogram QT prolonged, Vision disorder, Vomiting, Diarrhea, Constipation, Dyspepsia, Dysphagia, Abdominal pain, Pyrexia, Upper respiratory infection, Weight increased, Pain in extremity, Muscle spasm, Dizziness, Headache, Neutropenia, Lymphopenia, ALT elevation, AST elevation, Hypophosphatemia, pneumonia, acute respiratory distress syndrome, arrhythmia, respiratory failure, sepsis, neutropenia, Hypokalemia, fatigue, neuropathy, rash, renal cyst, hepatic failure, embryotoxicity, fetotoxicity"
332,XEOMIN,all-concat,"Hypersensitivity, Dysphagia, Breathing Difficulties, Spread of Effects from Toxin, Neck pain, Muscle weakness, Injection site pain, Musculoskeletal pain, Eyelid ptosis, Dry eye, Dry mouth, Diarrhea, Headache, Visual impairment, Dyspnea, Nasopharyngitis, Respiratory tract infection, Facial paresis, Injection site hematoma, Eyelid edema, Asthenia, Generalized muscle weakness, Diplopia, Blurred vision, Ptosis, Dysphonia, Dysarthria, Urinary incontinence, Eye swelling, Nausea, Flu-like symptoms, Injection site reaction, Allergic dermatitis, Localized allergic reactions like swelling, Edema, Erythema, Pruritus or rash, Herpes zoster, Muscle spasm, Myalgia, Corneal exposure, Corneal ulceration, Ectropion"
333,XIAFLEX,all-concat,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, flexor tendon rupture, pruritus, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, injection site swelling, injection site edema, blood blister, injection site hematoma, ecchymosis, penile ecchymoses, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain"
334,XTANDI,all-concat,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections or sepsis resulting in death, fall-related injuries, hypertensive crisis"
335,YERVOY,all-concat,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, intestinal perforation, hepatotoxicity, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, Stevens-Johnson syndrome, toxic epidermal necrolysis, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis"
336,ZERBAXA,all-concat,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment (including renal failure, renal failure acute), tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, dyspnea, urticaria, venous thrombosis"
337,ZYDELIG,all-concat,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, neutropenia, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, pneumonia, pyrexia, sepsis, febrile neutropenia, elevated transaminases, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, GGT increased, triglycerides increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
338,ZYKADIA,all-concat,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, increased ALT, increased AST, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased, sinus bradycardia"
339,ZYTIGA,all-concat,"fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, hypertension, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, hypokalemia, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain or chest discomfort, cardiac failure, constipation, groin pain, pyrexia, insomnia, falls, hematuria, rash, non-infectious pneumonitis, myopathy, rhabdomyolysis, hypernatremia"
